SHR-9839 drug page Clinical trials

Trials with SHR-9839

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
47Planned patients

Showing 1–1 of 1

A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Ongoing, not recruiting Phase 1 47 patients NCT06385678

The study is being conducted to evaluate the safety, tolerability, and efficacy of HRS-4642 in combination with antitumor medicine in patients with advanced solid tumors harboring KRAS G12D mutation.

China Jul 2024 – Aug 2026 Interventional
Combined with: AdebrelimabHRS-4642